Device and Diagnostics Dealmaking Quarterly Statistics, Q4 2011

26 Mar 2012

Medical device companies raised $800 million in the fourth quarter of 2011, and venture capital represented half of that amount. Just over $4 billion was spent to acquire medical device companies, down 50% from Q3’s $8 billion. In vitro diagnostics/research financings were well above the previous quarter, raking in a total of $269 million, with late-stage rounds again bringing in most of the Q4 money. Only five M&A deals were completed, totalling $915 million – way down from Q3’s $2.8 billion for the same number of deals.

Medical device companies raised $800 million in the fourth quarter, bringing the total 2011 funding for this industry to $4.1 billion, up 28% from 2010’s $3.2 billion. This increase was largely due to a jump in second-quarter financing attributed primarily to several big debt offerings – including NuVasive Inc.’s public sale of $341 million in convertible notes [See Deal] – plus a $107 million Series F from Cameron Health Inc.[See Deal] (See Exhibit 1.)

Exhibit 1